STAAR SURGICAL CO financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
STAA on Nasdaq
Location
Monrovia, CA
Fiscal year end
02 January
Latest financial report
03 Mar 2026

Quick Takeaways

  • STAA - STAAR SURGICAL CO financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2026.
  • Headline metric: Return On Equity -22%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+321%</span>.
  • Most recent SEC facts end date: 27 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-27) highlights Return On Equity -21.7%, Return On Assets -16.7%, and Operating Margin -38.3%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

24.1/100

Weak Confidence high

Return On Equity

-22%

Metric score 0.0/100

Return On Assets

-17%

Metric score 0.0/100

Financial Health

Current Ratio
4.55x
Quick Ratio
2.97x
Debt to Equity
0.3x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity -22% +321%
Return On Assets -17% +313%
Operating Margin -38% +853%

Financial Health

Metric Latest value YoY change
Current Ratio 4.55x -13%
Quick Ratio 2.97x -6.1%
Debt-to-equity 0.3x +16%

Growth

Metric Latest value YoY change
Revenues YoY -24%
NetIncomeLoss YoY -298%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 49,512,749 -0.03%
Common Stock, Shares, Outstanding 49,403,000 +0.22%
Common Stock, Value, Issued $498,000 +1%
Weighted Average Number of Shares Outstanding, Basic 49,568,000 +0.9%
Weighted Average Number of Shares Outstanding, Diluted 49,568,000 +0.9%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $40,055,000 -12%
Selling and Marketing Expense $102,528,000 -12%
General and Administrative Expense $85,783,000 -4.6%
Operating Income (Loss) $91,713,000 -627%
Nonoperating Income (Expense) $9,450,000 +166%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $82,263,000 -809%
Income Tax Expense (Benefit) $1,815,000 -116%
Earnings Per Share, Basic -1.62 -295%
Earnings Per Share, Diluted -1.62 -295%
Cash and Cash Equivalents, at Carrying Value $153,150,000 +6.2%
Accounts Receivable, after Allowance for Credit Loss, Current $50,064,000 -36%
Other Assets, Current $374,000 -63%
Assets, Current $311,545,000 -15%
Deferred Income Tax Assets, Net $3,365,000 +327%
Property, Plant and Equipment, Net $73,323,000 -14%
Operating Lease, Right-of-Use Asset $29,609,000 -20%
Goodwill $1,786,000 0%
Other Assets, Noncurrent $1,350,000 -8.2%
Assets $451,678,000 -11%
Accounts Payable, Current $11,574,000 -31%
Liabilities, Current $68,504,000 -2.6%
Operating Lease, Liability, Noncurrent $32,481,000 -6.7%
Liabilities $107,494,000 -4.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,511,000 +7.4%
Retained Earnings (Accumulated Deficit) $148,024,000 -119%
Stockholders' Equity Attributable to Parent $344,184,000 -13%
Liabilities and Equity $451,678,000 -11%
Common Stock, Shares Authorized 60,000,000 0%
Common Stock, Shares, Issued 49,779,000 +0.98%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $153,150,000 +6.2%
Deferred Tax Assets, Valuation Allowance $54,556,000 +17%
Deferred Tax Assets, Gross $67,862,000 +12%
Operating Lease, Liability $38,353,000 -0.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $79,928,000 -246%
Lessee, Operating Lease, Liability, to be Paid $48,707,000 -5.1%
Property, Plant and Equipment, Gross $112,888,000 -4.7%
Operating Lease, Liability, Current $5,872,000 +51%
Operating Lease, Weighted Average Discount Rate, Percent 0.0633 +5.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,354,000 -18%
Deferred Tax Assets, Operating Loss Carryforwards $50,662,000 +15%
Operating Lease, Payments $6,891,000 +15%
Deferred Tax Assets, Net of Valuation Allowance $13,306,000 -4%
Share-based Payment Arrangement, Expense $30,588,000 +12%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY